These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


132 related items for PubMed ID: 9855119

  • 1. Clinical and histopathologic examination of renal allografts treated with tacrolimus (FK506) for at least one year.
    Hatori M, Takahara S, Kyo M, Kokado Y, Nagano S, Okuyama A.
    Int J Urol; 1998 Nov; 5(6):526-33. PubMed ID: 9855119
    [Abstract] [Full Text] [Related]

  • 2. Morphological findings in non-episode biopsies of kidney transplant allografts treated with FK506 or cyclosporine.
    Kyo M, Hatori M, Takahara S, Kyakuno M, Nakamura T, Okada M, Kokado Y, Toki K, Ding XQ, Miki T, Miyamoto M, Okuyama A.
    Transpl Int; 1998 Nov; 11 Suppl 1():S100-3. PubMed ID: 9664955
    [Abstract] [Full Text] [Related]

  • 3. Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group.
    Solez K, Vincenti F, Filo RS.
    Transplantation; 1998 Dec 27; 66(12):1736-40. PubMed ID: 9884269
    [Abstract] [Full Text] [Related]

  • 4. Arteriolopathy in non-episode biopsies of renal transplant allograft.
    Toki K, Kyo M, Takahara S, Morozumi K, Ichimaru N, Tanaka T, Wang JD, Permpongkosol S, Oka K, Imai E, Miyamoto M, Kyakuno M, Nakamura T, Kojima Y, Kokado Y, Okuyama A.
    Clin Transplant; 2000 Dec 27; 14 Suppl 3():21-4. PubMed ID: 11092348
    [Abstract] [Full Text] [Related]

  • 5. Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies.
    Woodle ES, Cronin D, Newell KA, Millis JM, Bruce DS, Piper JB, Haas M, Josephson MA, Thistlethwaite JR.
    Transplantation; 1996 Oct 15; 62(7):906-10. PubMed ID: 8878382
    [Abstract] [Full Text] [Related]

  • 6. [A case of recurrent IgA nephropathy following renal transplantation under tacrolimus (FK506)].
    Takao T, Hatori M, Ichimaru N, Honda M, Nonomura N, Matsumiya K, Kokado Y, Takahara S, Okuyama A, Miyamoto M, Yokoyama K, Imai E, Kyo M.
    Hinyokika Kiyo; 1997 Sep 15; 43(9):661-4. PubMed ID: 9365847
    [Abstract] [Full Text] [Related]

  • 7. Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras.
    Nankivell BJ, PʼNg CH, OʼConnell PJ, Chapman JR.
    Transplantation; 2016 Aug 15; 100(8):1723-31. PubMed ID: 27306529
    [Abstract] [Full Text] [Related]

  • 8. [Histologic findings in protocol biopsies of transplanted kidneys].
    Tichý T, Tichý M, Zadrazil J, Krejcí K, Horcicka V, al-Jabry S, Bachleda P, Král V, Dusek J.
    Cesk Patol; 2003 Jan 15; 39(1):11-6. PubMed ID: 12673937
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
    Morrissey PE, Gohh R, Shaffer D, Crosson A, Madras PN, Sahyoun AI, Monaco AP.
    Transplantation; 1997 Mar 27; 63(6):845-8. PubMed ID: 9089224
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Renal interstitial fibrosis in children treated with FK506 for nephrotic syndrome.
    Morgan C, Sis B, Pinsk M, Yiu V.
    Nephrol Dial Transplant; 2011 Sep 27; 26(9):2860-5. PubMed ID: 21303962
    [Abstract] [Full Text] [Related]

  • 13. Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity.
    Haas M, Meehan SM, Josephson MA, Wit EJ, Woodle ES, Thistlethwaite JR.
    Am J Kidney Dis; 1999 Jul 27; 34(1):69-84. PubMed ID: 10401019
    [Abstract] [Full Text] [Related]

  • 14. Arteriosclerosis in zero-time biopsy is a risk factor for tacrolimus-induced chronic nephrotoxicity.
    Yagisawa T, Omoto K, Shimizu T, Ishida H, Tanabe K.
    Nephrology (Carlton); 2015 Jul 27; 20 Suppl 2():51-7. PubMed ID: 26031587
    [Abstract] [Full Text] [Related]

  • 15. Renal Allograft Histology at 10 Years After Transplantation in the Tacrolimus Era: Evidence of Pervasive Chronic Injury.
    Stegall MD, Cornell LD, Park WD, Smith BH, Cosio FG.
    Am J Transplant; 2018 Jan 27; 18(1):180-188. PubMed ID: 28710896
    [Abstract] [Full Text] [Related]

  • 16. Analysis of allograft biopsy specimens from long-term surviving patients with stable renal function: predictive value of long-term graft prognosis.
    Toki K, Takahara S, Moriyama T, Kyo M, Morozumi K, Yazawa K, Tanaka T, Wang JD, Permpongkosol S, Kokado Y, Okuyama A.
    Clin Transplant; 2002 Jan 27; 16 Suppl 8():24-30. PubMed ID: 12464128
    [Abstract] [Full Text] [Related]

  • 17. The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine.
    Randhawa PS, Shapiro R, Jordan ML, Starzl TE, Demetris AJ.
    Am J Surg Pathol; 1993 Jan 27; 17(1):60-8. PubMed ID: 7680544
    [Abstract] [Full Text] [Related]

  • 18. Molecular and structural consequences of early renal allograft injury.
    Baboolal K, Jones GA, Janezic A, Griffiths DR, Jurewicz WA.
    Kidney Int; 2002 Feb 27; 61(2):686-96. PubMed ID: 11849412
    [Abstract] [Full Text] [Related]

  • 19. Microvascular changes in renal allografts associated with FK506 (Tacrolimus) therapy.
    Randhawa PS, Tsamandas AC, Magnone M, Jordan M, Shapiro R, Starzl TE, Demetris AJ.
    Am J Surg Pathol; 1996 Mar 27; 20(3):306-12. PubMed ID: 8772784
    [Abstract] [Full Text] [Related]

  • 20. Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients.
    McKee M, Segev D, Wise B, Case B, Neu A, Fivush B, Colombani P.
    J Pediatr Surg; 1997 May 27; 32(5):688-90. PubMed ID: 9165452
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.